Prediction of Drug Pathway-based Disease Classes using Multiple Properties of Drugs
Authors:
- 1 November 2024
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Bioinformatics
- Vol. 19 (9) , 859-872
Abstract
Background: Drug repositioning now is an important research area in drug discovery as it can accelerate the procedures of discovering novel effects of existing drugs. However, it is challenging to screen out possible effects for given drugs. Designing computational methods are a quick and cheap way to complete this task. Most existing computational methods infer the relationships between drugs and diseases. The pathway-based disease classification reported in KEGG provides us a new way to investigate drug repositioning as such classification can be applied to drugs. A predicted class of a given drug suggests latent diseases it can treat. Objective: The purpose of this study is to set up efficient multi-label classifiers to predict the classes of drugs. Methods: We adopt three types of drug information to generate drug features, including drug pathway information, label information and drug network. For the first two types, drugs are first encoded into binary vectors, which are further processed by singular value decomposition. For the third type, the network embedding algorithm, Mashup, is employed to yield drug features. Above features are combined and fed into RAndom k-labELsets (RAKEL) to construct multi-label classifiers, where support vector machine is selected as the base classification algorithm. Results: The ten-fold cross-validation results show that the classifiers provide high performance with accuracy higher than 0.95 and absolute true higher than 0.92. The case study indicates the novel effects of three drugs, i.e., they may treat new diseases. Conclusion: The proposed classifiers have high performance and are superiority to the classifiers with other classic algorithms and drug information. Furthermore, they have the ability to discover new effects of drugs.Keywords
This publication has 55 references indexed in Scilit:
- Predicting gene phenotype by multi-label multi-class model based on essential functional featuresMolecular Genetics and Genomics, 2021
- DR2DI: a powerful computational tool for predicting novel drug-disease associationsJournal of Computer-Aided Molecular Design, 2018
- Compact Integration of Multi-Network Topology for Functional Analysis of GenesCell Systems, 2016
- Performance comparison of multi-label learning algorithms on clinical data for chronic diseasesComputers in Biology and Medicine, 2015
- Rapamycin: One Drug, Many EffectsCell Metabolism, 2014
- Extended-Connectivity FingerprintsJournal of Chemical Information and Modeling, 2010
- Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug UsesClinical Pharmacology & Therapeutics, 2009
- Rapamycin: An anti-cancer immunosuppressant?Critical Reviews in Oncology/Hematology, 2005
- Nizatidine treatment and its relationship with leptin levels in patients with olanzapine‐induced weight gainHuman Psychopharmacology: Clinical and Experimental, 2003
- Nizatidine for the treatment of patients with quetiapine‐induced weight gainHuman Psychopharmacology: Clinical and Experimental, 2003